Big biotech, Big pharma, Biotech, Diagnostics, Partnering, Pharma

Cardiorentis has established a pharma partnership with Roche

Posted on 17 October 2014

Tags: , , ,

Cardiorentis announced a pharma partnership with Roche to establish the therapeutic efficacy and safety of Ularitide.Ularitide is the Company's investigational drug for acute heart failure (AHF).

Cardiorentis will incorporate Roche's advanced in vitro diagnostic tests into its TRUE-AHF Phase III Study to characterize the pharmacological properties of Ularitide, evaluate its benefit-risk profile and the appropriate clinical application in patients.

The TRUE-AHF Phase III trial was initiated in August 2012.

For further deal information visit Current Agreements (subscription required)

Related

Report: Partnering Deals and Alliances with Roche

Report: Top 50 Big Pharma Partnering and M&A Deal Trends

Report: Top 50 Big Biotech Partnering and M&A Deal Trends

Browse: Complete Current Partnering report catalog

View: Partnering Scorecard in CP Insight– view top life science partnering deals by value

View: DealMetrics in CP Insight – the latest deal trend infographics for life science deal making

View: CP Insight’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

View: CP Insight’s Big Biotech Deal Making Scorecard – latest trends in big biotech deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter – reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter

Print Friendly, PDF & Email

Leave a Reply